With rising concern over the cost of the new Medicare prescription drug benefit program – going into effect January, 2006 and estimated to cost $593 billion over the next decade – a new UCSF study reveals that a key cost-cutting strategy employed by HMOs for 15 years is simply not working.

Researchers say an antibiotic used for topical applications looks promising to fight Huntington's disease in mice studies.

The UCSF Osher Lifelong Learning Institute (OLLI) kicks off its third year this fall with new courses for the public starting in October.

A thought-provoking exhibit, titled "Generations: A Tribute to Mothers and Daughters around the World," opens Thursday, Sept. 15 at UCSF.

Capitalizing on the strength of its research and clinical enterprise, UCSF is launching the Institute for Stem Cell and Tissue Biology, providing a framework for close collaboration among investigators from the University's Schools of Dentistry, Medicine, Nursing and Pharmacy.

Members of the Gladstone Institutes' Conklin lab and Embryonic Stem Cell Lab provided cells and helped train museum staff members for the development and launch of a current Exploratorium exhibit featuring live mouse embryonic stem cells.

A team of scientists from the Gladstone Institute of Cardiovascular Disease (GICD) has identified a key factor in heart development that could help advance gene therapy for treating cardiac disorders.

Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study by researchers at the UCSF ...

The California Institute for Regenerative Medicine (CIRM) has awarded the J. David Gladstone Institutes a $2.4 million grant to create a CIRM Scholars Training Program focusing on stem cell research.